Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report
Abstract. Background:. Allogeneic natural killer (NK) cell immunotherapy is recognized as a promising anti-tumor strategy, but whether it plays a role in poor CD4 recovery among human immunodeficiency virus type 1 (HIV-1) infected patients is unknown. This study aimed to investigate the safety and e...
| Huvudupphovsmän: | , , , , , , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Wolters Kluwer
2020-12-01
|
| Serie: | Chinese Medical Journal |
| Länkar: | http://journals.lww.com/10.1097/CM9.0000000000001189 |